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ABSTRACT 
A simple, rapid, precise and economical spectrophotometric method has been developed for 
quantitative analysis of rupatadine fumarate in bulk form. The objective of the present work is 
to develop and validate stability indicating simple and accurate method for the determination 
of Rupatidine fumarate using accurate UV spectroscopic method. The solutions of standard 
were prepared in methanol. Based on the solubility and physical parameters of the drug the 
standard stock solution of the drug was prepared and wavelength maxima were determined. 
The λmax was found to be 232nm. Based on the absorbance maxima of the drug dilutions were 
prepared and in the formulation estimated was carried out.  The method can be adopted in 
routine analysis of Rupatadine fumarate in bulk form and it involves relatively low cost 
solvents and no complex extraction techniques. The drug showed linearity in the range of 2-
10µg/ml with a correlation co-efficient of 0.999. The ruggedness was found to be 0.28%. The 
detection limit and quantification limit of the method were calculated as the 0.4714µg/ml and 
1.5557µg/ml. The method validated for different validation parameters such as linearity, 
accuracy, precision, detection limit, quantization limits, robustness, ruggedness and the results 
were found to be within the acceptance limits as per the guidelines of International Conference 
on Harmonisation (ICH). 
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INTRODUCTION 
Rupatadine fumarate is a dual histamine H1 
receptor and platelet activating factor receptor 
antagonist that is used for symptomatic relief in 
seasonal and perennial rhinitis as well as chronic 
spontaneous urticaria in adults and children. The 
chemical name of Rupatadine fumarate is (2E)-but-2-
enedioicacid; 13chloro-2- {1-[(5-methylpyridin-3-
yl)methyl] piperidin-4-ylidene}- 4azatricyclo [9,4,0,0 
{3,8}] pentadeca-1 (15), 3(8),4,6,11,13-hexaene. It 
has a molecular formula of C30H30ClN3O4. Rupatadine 
fumarate is a white coloured crystalline powder 
having solubility in methanol, ethanol, chloroform. 
The melting point of rupatadine fumarate is 
>1870C.[1] 
 
Figure 1: Structure of Rupatadine fumarate[2] 
It is having the purity 98.8-99%. It is available 
under the brand name Rupafin, Rupax. It was stored 
in dark place at 0-40c for days to weeks and at 200c 
for months to years. 
Rupatadine fumarate has a dual mechanism 
of action. It acts as a long acting, non sedative 
antagonist at histaminergic H1 receptors by 
competitively binding to it which is present on 
uterus, bronchus and large blood vessels etc. It is also 
antagonizing the platelet activating factor. Both 
histamine and PAF causes broncho-constriction and 
lead to an increase in the vascular permeability, 
acting as a mediator in the inflammatory process, 
which is responsible for the bronchial hyper 
reactivity.[3] 
MATERIALS AND METHODS 
Drug, solvents, chemicals 
Rupatadine fumarate was obtained as a gift 
sample from Hetero Pharmaceutical private limited, 
Nakkapalli. Methanol and distilled water are used as 
solvents for this method and were procured from the 
local market.  
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INSTRUMENTS 
Instruments employed for the study were 
 WENSAR weighing scales limited (weighing 
balance). 
 ELICO-Double beam SL-210/UV-Visible 
spectrophotometer with pair of 10 mm matched 
quartz cells. 
Preparation of reagents 
Preparation of stock 1 solution 
Weigh accurately 100mg of Rupatadine fumarate in a 
100ml volumetric flask and dilute with upto the mark 
to get concentration of 1000µg/ml. 
Preparation of stock 2 solution 
Take 1.0ml of above stock-1 solution and dilute with 
methanol in 100ml of volumetric flask to get 
concentration of 10µg/ml. 
Preparation of stock 3 solution 
From stock-1 solution, take 1.0ml and dilute with 
methanol in 10ml volumetric flask to get 
concentration of 100µg/ml. 
Preparation of NaOH solution (0.1N): 
Accurately weighed 4.0gms of NAOH and dissolved in 
few ml of water and final volume is make upto 
1000ml with distilled water and standardized. 
Preparation of 0.1N HCL solution 
Accurately measured 8.3ml of HCL and diluted in few 
ml of water and final volume is make upto 1000ml 
with distilled water and standardized. 
METHODOLOGY 
Method Development 
 
 
 
 
 
 
 
 
 
 
 
 
Based on the solubility and physical 
parameters of the drug the standard stock solution of 
the drug was prepared and wavelength maxima were 
determined. The λ max was found to be 232nm. 
Based on the absorbance maxima of the drug, 
different dilutions were prepared and the 
formulation estimation was carried out.[5] 
 
Selection of solvent 
The solubility of rupatadine fumarate was 
determined in a variety of solvents as per Indian 
pharmacopeia standards. Solubility test for 
rupatadine fumarate was carried out in different 
polar solvents. From the solubility studies, methanol 
was selected as suitable solvent for proposed 
method.[4] 
Selection of λ max 
The standard stock solution was further 
diluted with methanol to get 10µg/ml concentrations. 
The solution was scanned between 200-400nm range 
using methanol as blank. From the UV spectra 232nm 
was selected as for analysis of rupatadine fumarate. 
Figure 2: UV absorption spectrum of rupatadine 
fumarate at 232nm 
METHOD VALIDATION 
Linearity 
In this methanolic stock solution of 
rupatadine fumarate (0.2-1.0ml of 10µg/ml) were 
transferred into 100ml volumetric flask and made 
upto the mark with methanol. The absorbance of 
different concentration solutions were measured at 
232nm against blank. The sample was found to be 
linear from 2-10µg/ml the calibration curve was 
plotted using concentration vs absorbance. The curve 
obtained was linear in the concentration range of 2-
10µg/ml. 
Preparation of 2µg/ml solution 
From stock-3 solution, take 1.0ml and dilute with 
methanol in 50ml volumetric flask to get 
concentration of 2µg/ml. 
Preparation of 4µg/ml solution 
From stock-3 solution, take 2.0ml and dilute with 
methanol in 50ml volumetric flask to get 
concentration of 4µg/ml. 
Preparation of 6µg/ml solution 
From stock-3 solution, take 3.0ml and dilute with 
methanol in 50ml of volumetric flask to get 
concentration of 6µg/ml. 
Preparation of 8µg/ml solution 
From stock-3 solution, take 4.0ml and dilute with 
methanol in 50ml of volumetric flask to get 
concentration of 8µg/ml. 
Preparation of 10µg/ml solution 
From stock-3 solution, take 5.0ml and dilute with 
methanol in 50ml volumetric flask to get 
concentration of 10µg/ml. 
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Figure 3: Calibration curve of Rupatadine fumarate 
Precision
To evaluate the precision of the methods, 
pure drug solution (within working limits) was 
analyzed and being repeated 6 times of two different 
days. The relative error (%) and relative standard 
deviation (%) were found to be well within the 
acceptance criteria of below 2, indicate the high 
accuracy and precision for the proposed methods. 
Preparation of 6µg/ml stock solution 
From stock-3 solution, take 3.0ml and dilute 
with methanol in 50ml of volumetric flask to get 
concentration of 6µg/ml. 
Table 1: Precision result 
Precision %RSD 
Repeatability 0.22 
Intraday precision 0.35 
Inter day precision 0.31 
 
Ruggedness 
In order to determine this parameter the analysis 
was performed at same operational conditions and 
same environmental conditions but using different 
analysis. 
Table 2: Ruggedness result 
Parameter % RSD 
Ruggedness 0.28 
Limit of detection (LOD) and limit of 
quantification (LOQ): 
The detection limit and quantification limit of 
the method were calculated as the 0.4714µg/ml and 
1.5557µg/ml respectively. 
Table 3: Optical characteristics of Rupatadine fumarate by UV method 
Parameters Method values 
Wavelength λ (nm) 232nm 
Beer’s law limit (µg/ml) 3-21 
Sandell’s sensitivity (µg/cm2/0.001AU) 0.02296  
Molar absorbtivity (L mol-1 cm-1) 1.0677x104 
Correlation co-efficient (r) 0.999 
Regression equation (Y=mx+c) Y=0.050x +0.011 
Slope (m) 0.050 
Intercept (c) 0.011 
LOD(µg/ml) 0.4714 
LOQ(µg/ml) 1.5557 
Standard error of mean of regression line 0.001565 
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RESULTS AND DISCUSSIONS 
In the present work we have developed and 
validated UV spectroscopic method. The method was 
validated as per ICH guidelines. The linearity was 
found to be 2-10µg/ml for UV spectroscopic method 
showing the correlation coefficient of 0.999. The UV 
spectroscopic method was validated for linearity, 
precision, LOD, LOQ and ruggedness and the results 
were tabulated in table 1,2,3. All the results were 
found to be within the limits as per ICH guidelines 
and hence the proposed method was successfully 
employed for the determination of Rupatadine 
fumarate in its API for regular and routine analysis.  
CONCLUSION 
A simple, accurate, precise method was 
developed for the estimation of Rupatadine fumarate 
in bulk form. The method was validated as per ICH 
guidelines. 
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